It’s a start. But Medicare drug pricing is a national industrial policy that transfers billions of dollars from taxpayers and consumers to a favored industry. It’s a weird type of modern intra-economy mercantilism that increases national debt. Until deficits come down, perhaps Congress could negotiate with Pharma by paying a bit less for ALL drugs than in the previous year. (Lawmakers could shake down lobbyists for more $$ if cost containment had some bite.) No one would die as a result and drug companies arguably would face a greater incentive to invest in creating new drugs because it would be harder to profit from the current gravy train.